Development of crystalline keratopathy after intravitreal injections of pegaptanib.
Hamrah
P
P
Singh
P K
PK
Hoesl
L
L
Tezel
T H
TH
D000369:Aged, 80 and over; D052157:Aptamers, Nucleotide / Q000009:adverse effects*; D003316:Corneal Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D016896:Treatment Outcome; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors*
D052157:Aptamers, Nucleotide; D042442:Vascular Endothelial Growth Factors; C495058:pegaptanib